Name | c-ABL-IN-2 |
---|
Description | c-ABL-IN-2 is a potent inhibitor of c-Abl. Activation of c-Abl has been implicated in various diseases, notably cancer. c-ABL-IN-2 has the potential for the research of neurodegenerative diseases (amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD) and cancer (extracted from patent WO2020260871A1, compound 25)[1]. |
---|---|
Related Catalog | |
References |
[1]. Rebecca PAUL, et al. New compounds and methods. Patent WO2020260871A1. |
Molecular Formula | C21H20N4O |
---|---|
Molecular Weight | 344.41 |